On 10/13/25, Adverum Biotechnologies Inc (NASDAQ: ADVM) stock suffered a major decline of -13.5%, closing at $4.16. However, trading volume in this decline was below average at 76% of normal. The stock has been extremely weak relative to the market over the last nine months and has declined -22.8% during the last week.
Current PriceTarget Research Rating
Adverum Biotechnologies has a current Value Trend Rating of F (Lowest Rating). This rating combines consistent signals from two proprietary PTR measures of a stock’s attractiveness. Adverum Biotechnologies has a poor Appreciation Score of 26 and a very low Power Rating of 14, triggering the Lowest Value Trend Rating.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment